BCL2 and osteosarcoma: In osteosarcoma, the synergistic effect of the combined use of these two drugs was associated with increased apoptosis of cells as indicated by flow cytometry analysis and western blotting, which showed increased expression of cleaved PARP1, cleaved caspase 3, and BAX, and decreased expression of BCL2 [49].